.jpg)
I don't normally write articles based on Barchart.com data, such as the top 100 stocks to buy. However, struggling to develop a topic for my Wednesday commentary, I took a closer look at some of the names on the list.
There are a lot of interesting businesses on the list -- although I could do without all the biotech stocks -- that have hit it out of the park over the past 52 weeks.